The most common reasons include: Gastrointestinal side effects such as nausea, vomiting and diarrhea which are the single most frequently documented reason for stopping in large health system datasets High out of pocket cost and lack of insurance coverage particularly in individuals without diabetes Medication unavailability or pharmacy supply shortages which peaked in 2023early 2024 Perceived completion of therapy once target weight is reached or weight loss plateaus Concerns about long term safety or treatment burden of injections Many cohorts show substantial discontinuation by 3 months, with further losses by 6-9 months
The lesion appears as a focal, grey-to-black macule, and a history of injury can confirm the initial diagnosis
Hydroxocobalamin is bound to plasma proteins and stored in the liver
performed the literature search, and all authors drafted, reviewed, and critically revised the final manuscript
First, we explored the causal association of GLP-1RAs and ED by using an MR design, which was less susceptible to the effects of confounders, reverse causation, and various biases ( Despite these strengths, some limitations should be acknowledged
Weight management support Compounded GLP-1 medications mimic natural hormones to regulate appetite and digestion
